373 related articles for article (PubMed ID: 19841408)
1. Estimates of risk, empirical treatment observations, and unexpected laboratory findings reveal the complexity of nephrogenic systemic fibrosis.
High WA
Arch Dermatol; 2009 Oct; 145(10):1178-82. PubMed ID: 19841408
[No Abstract] [Full Text] [Related]
2. UV-A1 therapy for nephrogenic systemic fibrosis.
Tran KT; Prather HB; Cockerell CJ; Jacobe H
Arch Dermatol; 2009 Oct; 145(10):1170-4. PubMed ID: 19841406
[TBL] [Abstract][Full Text] [Related]
3. Detection of clonal T cells in the circulation of patients with nephrogenic systemic fibrosis.
Kreuter A; Höxtermann S; Gambichler T; Tigges C; Hahn SA; Schieren G
Arch Dermatol; 2009 Oct; 145(10):1164-9. PubMed ID: 19841405
[TBL] [Abstract][Full Text] [Related]
4. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of dermal cellularity in nephrogenic systemic fibrosis: a diagnostic aid.
Nazarian RM; Mandal RV; Kagan A; Kay J; Duncan LM
J Am Acad Dermatol; 2011 Apr; 64(4):741-7. PubMed ID: 21414498
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
Heinz-Peer G; Neruda A; Watschinger B; Vychytil A; Geusau A; Haumer M; Weber M
Eur J Radiol; 2010 Oct; 76(1):129-34. PubMed ID: 19619969
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic systemic fibrosis and use of MR contrast media].
Christiansen RE; Sviland L; Sekse I; Svarstad E
Tidsskr Nor Laegeforen; 2009 Jan; 129(3):180-2. PubMed ID: 19180161
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
Wilford C; Fine JD; Boyd AS; Sanyal S; Abraham JL; Kantrow SM
Am J Dermatopathol; 2010 Feb; 32(1):71-5. PubMed ID: 19940755
[TBL] [Abstract][Full Text] [Related]
10. Ten-year experience with nephrogenic systemic fibrosis: case-control analysis of risk factors.
Bahrami S; Raman SS; Sauk S; Salehmoghaddam S; Villablanca JP; Finn JP; Lu DS
J Comput Assist Tomogr; 2009; 33(6):819-23. PubMed ID: 19940643
[TBL] [Abstract][Full Text] [Related]
11. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
Jikki PN
J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
[No Abstract] [Full Text] [Related]
13. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
15. A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
Weiss AS; Lucia MS; Teitelbaum I
Nat Clin Pract Nephrol; 2007 Feb; 3(2):111-5. PubMed ID: 17251999
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.
Wang SC
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):305-6. PubMed ID: 18811752
[No Abstract] [Full Text] [Related]
17. Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.
Schieren G; Wirtz N; Altmeyer P; Rump LC; Weiner SM; Kreuter A
J Am Acad Dermatol; 2009 Nov; 61(5):868-74. PubMed ID: 19836645
[TBL] [Abstract][Full Text] [Related]
18. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
van der Molen AJ
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):339-50. PubMed ID: 18811757
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic systemic fibrosis developed after recovery from acute renal failure: gadolinium as a possible aetiological factor.
Lu CF; Hsiao CH; Tjiu JW
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):339-40. PubMed ID: 18573157
[No Abstract] [Full Text] [Related]
20. Gadolinium and systemic fibrosis: guilt by association.
Kay J; Czirják L
Ann Rheum Dis; 2010 Nov; 69(11):1895-7. PubMed ID: 20959325
[No Abstract] [Full Text] [Related]
[Next] [New Search]